EUVIMEDEUVIMED entdecken
Systematische ÜbersichtOpen Access · CC BY 4.0

Diagnostic utility of FAPI PET/CT in radioiodine-refractory thyroid cancer and TENIS syndrome: a systematic review

Akram Al-Ibraheem, Saad Ruzzeh, Ahmad Al-Muhtaseb, Ahmed Saad Abdlkadir, Serin Moghrabi, Hongcheng Shi, Habibollah Dadgar, Mahed Al-Foqahaa, Marwah Abdulrahman, Soud Al-Qasem, Issa Mohamad, Gerasimos P Sykiotis

Oncology Reviews · 03.06.2026 · 20

DOI: 10.3389/or.2026.1811291 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Oncology Reviews, online erschienen am 03.06.2026. Verfasst von Akram Al-Ibraheem und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fibroblast activation protein inhibitor (FAPI) positron emission tomography/computed tomography (PET/CT) has emerged as a promising molecular imaging modality with favorable lesion-to-background contrast across several malignancies. In radioiodine-refractory thyroid carcinoma (RAIR-TC) and thyroglobulin-elevated negative iodine scintigraphy (TENIS) syndrome, conventional radioiodine imaging and fluorodeoxyglucose (FDG) PET/CT may be limited in selected clinical scenarios. This systematic review evaluated the diagnostic utility, comparative performance, and potential clinical impact of FAPI PET/CT in this patient population.

Methods

PubMed, Embase, and Scopus were searched from inception to 6 August 2025 according to PRISMA 2020 guidelines. Eligible studies included original clinical studies and case reports evaluating FAPI PET/CT in RAIR-TC or TENIS syndrome. Non-original, non-human, in vitro , conference abstract, and non-English publications were excluded. Two reviewers independently performed study selection, data extraction, and quality assessment. QUADAS-2 was applied to eligible cohort studies.

Results

Eight studies comprising 167 patients were included: three prospective studies, one retrospective study, and four case reports. FAPI PET/CT showed promising complementary diagnostic value in selected clinical scenarios, particularly for lesions with low FDG conspicuity or high physiologic FDG background. In one prospective cohort of 24 patients, [ 68 Ga]Ga-DOTA-FAPI-04 PET/CT detected disease in 87.5% of patients. In the largest retrospective cohort (n = 117), [ 68 Ga]Ga-DOTA.SA.FAPi showed higher detection than FDG PET/CT for selected metastatic sites, including lymph nodes, liver, and brain. However, comparative performance varied across tracers, lesion sites, and study designs; one prospective [ 18 F]FAPI-74 study reported lower lesion detection than FDG PET/CT.

Conclusion

FAPI PET/CT demonstrates promising but preliminary diagnostic utility in RAIR-TC and TENIS syndrome. Current evidence supports a complementary role in selected patients, but remains insufficient to establish routine diagnostic superiority over FDG PET/CT. Larger prospective multicenter studies with standardized protocols and robust reference validation are required. Systematic Review Registration https://www.crd.york.ac.uk/PROSPERO/view/CRD420251123809 .

Schlagwörter

Stichwörter der Autor:innen

FAPI PET/CTFDG PET/CTRAIRTENIS syndromedifferentiated thyroid carcinomamolecular imaging

Autor:innen und Institutionen

  • Department of Nuclear Medicine, King Hussein Cancer Center (KHCC), Amman, Jordan.
  • School of Medicine, University of Jordan, Amman, Jordan.
  • Department of Radiology, Istishari Hospital, Amman, Jordan.
  • Department of Nuclear Medicine, Baghdad Radiotherapy and Nuclear Medicine Hospital, Bab Al-Muadham, Baghdad, Iraq.
  • Department of Nuclear Medicine, Zhongshan Hospital, Fudan University, Shanghai, China.
  • Nuclear Medicine Research Center, Mashhad University of Medical Sciences, Mashhad, Iran.

Zitieren

APA

Al-Ibraheem, A., Ruzzeh, S., Al-Muhtaseb, A., Abdlkadir, A. S., Moghrabi, S., Shi, H., Dadgar, H., Al-Foqahaa, M., Abdulrahman, M., Al-Qasem, S., Mohamad, I., & Sykiotis, G. P. (2026). Diagnostic utility of FAPI PET/CT in radioiodine-refractory thyroid cancer and TENIS syndrome: a systematic review. Oncology Reviews, 20. https://doi.org/10.3389/or.2026.1811291

Vancouver

Al-Ibraheem A, Ruzzeh S, Al-Muhtaseb A, Abdlkadir AS, Moghrabi S, Shi H, et al. Diagnostic utility of FAPI PET/CT in radioiodine-refractory thyroid cancer and TENIS syndrome: a systematic review. Oncology Reviews. 2026;20. doi:10.3389/or.2026.1811291

BibTeX
@article{AlIbraheem2026,
  author = {Al-Ibraheem, Akram and Ruzzeh, Saad and Al-Muhtaseb, Ahmad and Abdlkadir, Ahmed Saad and Moghrabi, Serin and Shi, Hongcheng and Dadgar, Habibollah and Al-Foqahaa, Mahed and Abdulrahman, Marwah and Al-Qasem, Soud and Mohamad, Issa and Sykiotis, Gerasimos P},
  title = {Diagnostic utility of FAPI PET/CT in radioiodine-refractory thyroid cancer and TENIS syndrome: a systematic review},
  journal = {Oncology Reviews},
  year = {2026},
  volume = {20},
  doi = {10.3389/or.2026.1811291}
}
Kostenlos starten →